Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin add-on to NSAIDs for neuropathic pain due to lumbar disc herniation
jRCTs061220102Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mirogabalin in Neuralgia (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Change in lower limb pain NRS. Started Mar 2023; status: completed.
02
Drugs
mirogabalin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on jRCTs061220102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220102.